Prevail Partners
Overview
Prevail Partners is a private equity firm investing in life sciences companies. The firm focuses on clinical-stage biotech and pharmaceutical companies, providing capital to support the development of therapeutics, preventive treatments, medical devices, and diagnostics. Prevail Partners employs proprietary technologies and services through its affiliate, Prevail InfoWorks, to enhance the success rates of clinical trials for its portfolio companies.
Investment Focus
- Clinical-stage biotech and pharmaceutical companies
- Therapeutics, preventive treatments, medical devices, diagnostics
Portfolio Companies
Reach Prevail Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Prevail Partners
What sectors does Prevail Partners invest in?
Prevail Partners invests in Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Pennsylvania, United States. Prevail Partners is listed as a private equity in the ConnectSafely investor database.
What stage does Prevail Partners invest at?
Prevail Partners backs companies at Early Stage, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Prevail Partners invest in?
Prevail Partners invests across United States.
What companies has Prevail Partners invested in?
Prevail Partners's portfolio includes Coologics, Kairos Pharma and TNF Pharmaceuticals.
Last updated · Source: ConnectSafely investor database
